Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

GlobeNewswire10/31 20:35

Silo Pharma Shares Are Trading Lower After the Company Completed a Pre-investigational New Drug Meeting With the FDA for SPOC-15, an Intranasal Prophylactic Treatment for PTST and Stress-induced Anxiety Disorder.

Benzinga09/10 22:52

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Yahoo Finance09/10 18:35

Silo Pharma Files for Secondary Stock Offering

Seeking Alpha08/22 05:52

Silo Pharma Shares Jump 11% on Ketamine-Treatment Partnership

WSJ08/15 02:56

サイロ・ファーマ | 10-Q：Q2 2024 四半期報告書

SEC08/14 04:36